Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Crawford Nomination To Be FDA Commissioner Clears Senate 78-16

This article was originally published in The Pink Sheet Daily

Executive Summary

Three Republicans, 13 Democrats vote against the acting commissioner. Finance Committee chair Grassley says that Crawford “has not stepped up to the plate” to address systemic problems at FDA.

You may also be interested in...



FDA Stresses Stability Following Commissioner Crawford's Resignation

HHS Secretary Leavitt praises Crawford and Acting Commissioner von Eschenbach while underscoring the experienced leadership remaining at the agency in a memo to FDA staff.

FDA Stresses Stability Following Commissioner Crawford's Resignation

HHS Secretary Leavitt praises Crawford and Acting Commissioner von Eschenbach while underscoring the experienced leadership remaining at the agency in a memo to FDA staff.

FDA Commissioner Crawford Resigns

Announcement comes after he had been full commissioner for barely two months.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS062566

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel